TCM for Coal Worker's Pneumoconiosis

• Status: Recruiting
• Trial end date: 2022-12-30
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to evaluate the clinical efficacy of traditional Chinese medicine in the treatment of pneumoconiosis and to provide high-quality evidence for the prevention and treatment of pneumoconiosis.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Henan University of Traditional Chinese Medicine

Criteria

Inclusion Criteria:

1. Pneumoconiosis (coal workers' pneumoconiosis) patients aged 18 to 75 years;

2. Comply with TCM syndrome differentiation standards;

3. Sign informed consent forms.

Exclusion Criteria:

1. Patients who do not get rid of the dust;

2. Patients with active tuberculosis, idiopathic pulmonary fibrosis, asthma, bronchiectasis, pulmonary embolism, chronic respiratory failure or other severe respiratory diseases;

3. Acute exacerbations occurred within 1 month before selection;

4. Patients with severe cardiovascular and cerebrovascular diseases (malignant arrhythmia, unstable angina, acute myocardial infarction, HF New York Heart Association classes III to IV, stroke, cerebral hemorrhage);

5. Patients with severe liver and kidney disease (liver cirrhosis, portal hypertension, dialysis, kidney transplantation);

6. Tumor patients undergoing resection, radiotherapy and chemotherapy within 5 years before selection;

7. Patients with activity difficulties caused by neuromuscular diseases;

8. Patients with severe arthritis;

9. Patients with severe peripheral vascular disease;

10. Pregnant and lactating women;

11. Patients with severe cognitive and mental disorders;

12. Clinical investigators who are participating in other interventions within 1 month before selection.